• 1
    National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A. Wayne PA: NCCLS, 1997.
  • 2
    Ghannoum MA, Rex J, Galgiani JN. Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome. J Clin Microbiol 1996; 34: 48995.
  • 3
    Laerum OD & Farsund T. Clinical application of flow cytometry: a review. Cytometry 1981; 2: 113.
  • 4
    Boye E, Steen HB, Skarstad K. Flow cytometry of bacteria: a promising tool in experimental and clinical microbiology. J Gen Microbiol 1983; 129: 97380.
  • 5
    Pore RS. Antibiotic susceptibility testing of Candida albicans by flow cytometry. Current Microbiol 1990; 20: 3238.
  • 6
    Davey HM & Kell DB. Flow cytometry and cell sorting of heterogeneous microbial populations: the importance of single-cell analyses. Microbiol Rev 1996; 60: 64196.
  • 7
    Kirk SM, Callister SM, Lim LCL, Schell RF. Rapid susceptibility testing of Candida albicans by flow cytometry. J Clin Microbiol 1997; 35: 35863.
  • 8
    Durodie J, Coleman K, Simpson IN, Loughbourgh SH, Winsta DW. Rapid detection of antimicrobial activity using flow cytometry. Cytometry 1995; 21: 3747.
  • 9
    Green L, Petersen B, Steimel L, Haeber P, Current W. Rapid determination of antifungal activity by flow cytometry. J Clin Microb 1994; 32: 108891.
  • 10
    Liao R, Rennie R, Talbot JA. Assessment of the effect of amphotericin B on the vitality of Candida albicans. Antimicrob Agents Chemother 1999; 43: 103441.
  • 11
    Shapiro HM. Pratical Flow Cytometry, 2nd edn. New York: Alan R Liss, 1988.
  • 12
    Bauer KD. Quality control issues in DNA content flow cytometry. In: Ann N Y Acad Sci 1993; 677: 5977.
  • 13
    Millard PJ, Roth BL, Truong Yhi H-P, Yue ST, Haugland RP. Development of the FUN-1 Family of Fluorescent Probes for vacuole labeling and viability testing of yeasts. Appl Environ Microbiol 1997; 63: 2897905.
  • 14
    Reers M, Smith TW, Chen LB. J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential. Biochemistry 1991; 30: 44806.
  • 15
    Cossarizza A, Baccarani-Contri M, Kalashnikova G, Franceschi C. A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the JC-aggregate forming lipophilic cation 5,5′′,6,6′-tretrachoro-1,1′,3,3′-tetraethylbenzidazolcarbocyanine iodide (JC-1). Biochem Biophys Res Commun 1993; 197: 405.DOI: 10.1006/bbrc.1993.2438
  • 16
    Cossarizza A, Kalashnikova G, Grassilli E et al. Mitochondrial modifications during rat thymocyte apoptosis: a stdy at the single cell level. Exp Cell Res 1994; 214: 32330.DOI: 10.1006/excr.1994.1264
  • 17
    Prudêncio C, Sansonetty F, Côrte-Real M. Flow cytometric asessment of cell structural and functional changes induced by acetic acid in the yeasts Zygosaccharomyces bailii and Saccharomyces cerevisiae. Cytometry 1998; 31: 30713.
  • 18
    O'Gorman MRG & Hopfer RL. Amphotericin B susceptibility testing of Candida species by flow cytometry. Cytometry 1991; 12: 7437.
  • 19
    Ramani R, Ramani A, Wong SJ. Rapid flow cytometric susceptibility testing of Candida albicans. J Clin Microbiol 1997; 35: 23204.
  • 20
    Pina-Vaz C, Sansonetty F, Rodrigues A, Martinez-de-Oliveira J, Fonseca AF, Mardh P-A. Antifungal activity of ibuprofen alone and in combination with fluconazole against Candida species. J Med Microbiol 2000; 49: 110.
  • 21
    Pina-Vaz C, Rodrigues A, Sansonetty F, Martinez-de-Oliveira J, Fonseca AF, Mardh P-A. Antifungal activity of local anesthetics against Candida species. Inf Dis Obst Gynecol 2000; 8: 12437.
  • 22
    Green LJ, Marder P, Mann L, Chio L-C, Current W. LY303366 exhibits rapid and potent fungicidal activity in flow cytometry of yeast viability. Antimicrob Agents Chemother 1999; 43: 8305.
  • 23
    Beggs W. Physicochemical cell damage in relation to lethal amphotericin B action. Antimicrob Agents Chemother 1994; 38: 3634.
  • 24
    Peyron F, Guiraud-Dauriac H, Mzibri ME et al. Evaluation of a flow cytometric method for rapid determination of amphotericin B susceptibility of yeast isolates. Antimicrob Agents Chemother 1997; 41: 153740.
  • 25
    Ordóñes JV & Wehman NM. Amphotericin B susceptibility of Candida species assessed by rapid flow cytometric membrane potential assay. Cytometry 1995; 22: 1547.
  • 26
    Pina-Vaz C, Sansonetty F, Rodrigues AG, Costa-de-Oliveira S, Martinez-de-Oliveira J, Fonseca AF. Susceptibility to fluconazole of Candida clinical isolates determined by FUN-1 staining and flow cytometry or epifluorescence microscopy. J Med Microbiol 2001; 50: 18.
  • 27
    White TC, March KA, Bowden RA. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev 1998; 11: 382402.